Osteopontin expression and relation to disease severity in human asthma

European Respiratory Journal

Volumn 37, Issue 2, 2011, Pages 331-341

  Samitas, K ^a,c,d   Zervas, E ^a   Vittorakis, S ^a,c   Semitekolou, M ^c   Alissafi, T ^c   Bossios, A ^d   Gogos, H ^b   Economidou, E ^a   Lotvall J ^d   Xanthou, G ^c   Panoutsakopoulou, V ^c   Gaga, M ^a  

^a 7th Respiratory Medicine Dept   (Greece)

^b Hospital for Diseases of the Chest SOTIRIA   (Greece)

^c Biomedical Research Foundation   (Greece)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Airway remodelling; Allergic inflammation; Asthma; Basement membrane; Osteopontin; Research bronchoscopy

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; OSTEOPONTIN; PLACEBO; PREDNISOLONE;

ADULT; AGED; AIRWAY REMODELING; ARTICLE; ASTHMA; BASEMENT MEMBRANE; BREATHING MUSCLE; BRONCHOSCOPY; BRONCHUS BIOPSY; BRONCHUS MUCOSA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; GOBLET CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPLASIA; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MAST CELL; MYOFIBROBLAST; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; STEADY STATE; T LYMPHOCYTE; VASCULAR SMOOTH MUSCLE;

ADULT; AGED; AIRWAY REMODELING; ASTHMA; BASEMENT MEMBRANE; BRONCHI; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CROSS-SECTIONAL STUDIES; FEMALE; GOBLET CELLS; HUMANS; MALE; MAST CELLS; MIDDLE AGED; MYOFIBROBLASTS; OSTEOPONTIN; SEVERITY OF ILLNESS INDEX; UP-REGULATION;

EID: 78650568154     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00017810     Document Type: Article

References (34)

1. James AL, Wenzel S. Clinical relevance of airway remodelling in airway diseases. Eur Respir J 2007; 30: 134-155. (Pubitemid 47074016)
2. Butler WT. Structural and functional domains of osteopontin. Ann N Y Acad Sci 1995; 760: 6-11.
3. Weber GF, Ashkar S, Glimcher MJ, et al. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 1996; 271: 509-512. (Pubitemid 26044470)
4. Shinohara ML, Kim HJ, Kim JH, et al. Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells. Proc Natl Acad Sci USA 2008; 105: 7235-7239. (Pubitemid 351754461)
5. Koh A, da Silva AP, Bansal AK, et al. Role of osteopontin in neutrophil function. Immunology 2007; 122: 466-475. (Pubitemid 350075961)
6. Patarca R, Freeman GJ, Singh RP, et al. Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection. J Exp Med 1989; 170: 145-161. (Pubitemid 19179701)
7. Ashkar S, Weber GF, Panoutsakopoulou V, et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 2000; 287: 860-864. (Pubitemid 30084330)
8. O'Regan A. The role of osteopontin in lung disease. Cytokine Growth Factor Rev 2003; 14: 479-488. (Pubitemid 37296021)
9. Pardo A, Gibson K, Cisneros J, et al. Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis. PLoS Med 2005; 2: e251.
10. Lu X, Zhang XH, Wang H, et al. Expression of osteopontin in chronic rhinosinusitis with and without nasal polyps. Allergy 2009; 64: 104-111.
11. Konno S, Golden DB, Schroeder J, et al. Increased expression of osteopontin is associated with long-term bee venom immunotherapy. J Allergy Clin Immunol 2005; 115: 1063-1067. (Pubitemid 40616224)
12. Puxeddu I, Berkman N, Ribatti D, et al. Osteopontin is expressed and functional in human eosinophils. Allergy 2010; 65: 168-174.
13. Takahashi A, Kurokawa M, Konno S, et al. Osteopontin is involved in migration of eosinophils in asthma. Clin Exp Allergy 2009; 39: 1152-1159.
14. Xanthou G, Alissafi T, Semitekolou M, et al. Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets. Nat Med 2007; 13: 570-578. (Pubitemid 46828486)
15. Simoes DC, Xanthou G, Petrochilou K, et al. Osteopontin deficiency protects against airway remodeling and hyperresponsiveness in chronic asthma. Am J Respir Crit Care Med 2009; 179: 894-902.
16. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. NHLBI/WHO workshop Report. Updated 2009. New York, Medical Communications Resources, Inc., 2010.
17. Reddel HK, Taylor DR, Bateman ED, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009; 180: 59-99.
18. Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004; 113: 832-836. (Pubitemid 38608590)
19. Samitas K, Chorianopoulos D, Vittorakis S, et al. Exhaled cysteinylleukotrienes and 8-isoprostane in patients with asthma and their relation to clinical severity. Respir Med 2009; 103: 750-756.
20. Jeffery P, Holgate S, Wenzel S. Methods for the assessment of endobronchial biopsies in clinical research: application to studies of pathogenesis and the effects of treatment. Am J Respir Crit Care Med 2003; 168: S1-S17. (Pubitemid 37175959)
21. Haslam PL, Baughman RP. Report of ERS Task Force: guidelines for measurement of acellular components and standardization of BAL. Eur Respir J 1999; 14: 245-248. (Pubitemid 29461283)
22. Bourdin A, Neveu D, Vachier I, et al. Specificity of basement membrane thickening in severe asthma. J Allergy Clin Immunol 2007; 119: 1367-1374. (Pubitemid 46855858)
23. Saetta M, Turato G, Baraldo S, et al. Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation. Am J Respir Crit Care Med 2000; 161: 1016-1021. (Pubitemid 30171766)
24. Andre E, Stoeger T, Takenaka S, et al. Inhalation of ultrafine carbon particles triggers biphasic pro-inflammatory response in the mouse lung. Eur Respir J 2006; 28: 275-285. (Pubitemid 44920001)
25. Nagasaka A, Matsue H, Matsushima H, et al. Osteopontin is produced by mast cells and affects IgE-mediated degranulation and migration of mast cells. Eur J Immunol 2008; 38: 489-499.
26. Sodek J, Batista Da Silva AP, Zohar R. Osteopontin and mucosal protection. J Dent Res 2006; 85: 404-415. (Pubitemid 43799256)
27. Lenga Y, Koh A, Perera AS, et al. Osteopontin expression is required for myofibroblast differentiation. Circ Res 2008; 102: 319-327. (Pubitemid 351271652)
28. Fahy JV. Remodeling of the airway epithelium in asthma. Am J Respir Crit Care Med 2001; 164: S46-S51.
29. Chen Y, Nickola TJ, DiFronzo NL, et al. Dexamethasone-mediated repression of MUC5AC gene expression in human lung epithelial cells. Am J Respir Cell Mol Biol 2006; 34: 338-347. (Pubitemid 43320715)
30. Hansel NN, Cheadle C, Diette GB, et al. Analysis of CD4+ T-cell gene expression in allergic subjects using two different microarray platforms. Allergy 2008; 63: 366-369. (Pubitemid 351224669)
31. Kaarteenaho-Wiik R, Paakko P, Sormunen R. Ultrastructural features of lung fibroblast differentiation into myofibroblasts. Ultrastruct Pathol 2009; 33: 6-15.
32. 3 in rat bone organ cultures. Connect Tissue Res 1996; 34: 41-51.
33. Kirton JP, Wilkinson FL, Canfield AE, et al. Dexamethasone downregulates calcification-inhibitor molecules and accelerates osteogenic differentiation of vascular pericytes: implications for vascular calcification. Circ Res 2006; 98: 1264-1272. (Pubitemid 43948081)
34. Kurokawa M, Konno S, Matsukura S, et al. Effects of corticosteroids on osteopontin expression in a murine model of allergic asthma. Int Arch Allergy Immunol 2009; 149: Suppl. 1, 7-13.